Douglas J. Jolly
Vorsitzender bei American Society of Gene Therapy
Profil
Douglas J.
Jolly was the founder of Tocagen, Inc. (founded in 2007) where he held the title of EVP-Research & Pharmaceutical Development until 2020, and Abintus Bio, Inc. (founded in 2020) where he held the title of Principal.
Dr. Jolly's current job is Chairman at the American Society of Gene Therapy.
Dr. Jolly's former jobs include being a Principal at Chiron Viagene, Inc., the University of California, Berkeley, National Institutes of Health, Scripps Clinic Foundation, Weizmann Institute of Science, and BioMedica Diagnostics, Inc., and being the President of The Advantage, Inc., Oxford Biomedical Research, Inc., and BioMedica Diagnostics, Inc. Dr. Jolly received a doctorate degree from the University of Glasgow.
Dr. Jolly is also the founder of Chiron Corp...
Aktive Positionen von Douglas J. Jolly
| Unternehmen | Position | Beginn |
|---|---|---|
| American Society of Gene Therapy | Vorsitzender | 30.04.2009 |
Ehemalige bekannte Positionen von Douglas J. Jolly
| Unternehmen | Position | Ende |
|---|---|---|
| FORTE BIOSCIENCES, INC. | Gründer | 14.04.2020 |
Abintus Bio, Inc.
 Abintus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Abintus Bio, Inc. operates as a preclinical stage gene therapy company. It provides immune cell reprogramming services. The company was founded by John Snyder, Nicholas A. Boyle, Douglas J. Jolly, Carlos Ibañez, Derek Ostertag, and Cory Bentley and is headquartered in Encinitas, CA. | Gründer | - |
BioMedica Diagnostics, Inc.
 BioMedica Diagnostics, Inc. Medical/Nursing ServicesHealth Services BioMedica Diagnostics, Inc. specializes in providing haemostasis and thrombosis diagnostics for both human and animal health. The private company is based in Windsor, Canada. The Canadian company offers a comprehensive range of specialty coagulation and diagnostic products. | Präsident | - |
| Institut National de Recherche en Informatique et Automatique | Corporate Officer/Principal | - |
| University of California, Berkeley | Corporate Officer/Principal | - |
Ausbildung von Douglas J. Jolly
| University of Glasgow | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Tocagen, Inc.
 Tocagen, Inc. BiotechnologyHealth Technology Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer. It is in the business of discovery, development, and commercialization of products for the treatment of cancer. The company was founded by Thomas E. Darcy, Harry E. Gruber, Douglas J. Jolly, and Dennis N. Berman in August 2007 and is headquartered San Diego, CA. | Health Technology |
Chiron Viagene, Inc.
 Chiron Viagene, Inc. Miscellaneous Commercial ServicesCommercial Services Chiron Viagene, Inc. provides technical services and life science research. The company is based in San Diego, CA. The company specializes in EMSA reagents and services, as well as producing innovative technology. The company was founded by Paul K. Laikind, David F. Hale, Jack W. Reich, Harry E. Gruber. Chiron Viagene was acquired by Chiron Corp. on October 03, 1995 for $135 million. | Commercial Services |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
| Scripps Clinic Foundation | Health Services |
The Advantage, Inc.
 The Advantage, Inc. Miscellaneous Commercial ServicesCommercial Services The Advantage, Inc. provides career guiding services. It offers career coaching services such as interviewing, salary negotiation and personality assessment. The company was founded in 1986 and is headquartered in Myrtle Beach, SC. | Commercial Services |
Oxford Biomedical Research, Inc.
 Oxford Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Oxford Biomedical Research (OBR) develops, manufactures and markets assay kits, recombinant proteins and antibodies for biomedical research and drug discovery. The company's primary focus is on the identification and assay of biomarkers for oxidative stress and chronic inflammation, two major risk factors for multiple diseases. OBR is employing proprietary technology to develop tissue and disease specific biomarkers. ProteoMine™ is a cost effective tool for removing high abundance proteins for biomarker discovery. ToxProfiler™ technology captures and detects oxidized proteins in blood correlated with organ-specific toxicity and disease. New platform technologies such as Toxic proteomics and Metabolomics are being applied, adapted and modified into new and practical ways for the diagnosis of early onset disease and for the prevention of diseases. The company was founded in 1984 and is headquartered in Rochester Hills, MI. | Commercial Services |
| American Society of Gene Therapy | |
BioMedica Diagnostics, Inc.
BioMedica Diagnostics, Inc. Medical/Nursing ServicesHealth Services BioMedica Diagnostics, Inc. specializes in providing haemostasis and thrombosis diagnostics for both human and animal health. The private company is based in Windsor, Canada. The Canadian company offers a comprehensive range of specialty coagulation and diagnostic products. | Health Services |
Abintus Bio, Inc.
Abintus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Abintus Bio, Inc. operates as a preclinical stage gene therapy company. It provides immune cell reprogramming services. The company was founded by John Snyder, Nicholas A. Boyle, Douglas J. Jolly, Carlos Ibañez, Derek Ostertag, and Cory Bentley and is headquartered in Encinitas, CA. | Commercial Services |
